436 related articles for article (PubMed ID: 23737759)
1. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
Bockstaele L; Bisteau X; Paternot S; Roger PP
Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
[TBL] [Abstract][Full Text] [Related]
3. A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression.
Schachter MM; Merrick KA; Larochelle S; Hirschi A; Zhang C; Shokat KM; Rubin SM; Fisher RP
Mol Cell; 2013 Apr; 50(2):250-60. PubMed ID: 23622515
[TBL] [Abstract][Full Text] [Related]
4. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase.
Paternot S; Bockstaele L; Bisteau X; Kooken H; Coulonval K; Roger PP
Cell Cycle; 2010 Feb; 9(4):689-99. PubMed ID: 20107323
[TBL] [Abstract][Full Text] [Related]
5. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP
Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
[TBL] [Abstract][Full Text] [Related]
8. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.
Ray A; James MK; Larochelle S; Fisher RP; Blain SW
Mol Cell Biol; 2009 Feb; 29(4):986-99. PubMed ID: 19075005
[TBL] [Abstract][Full Text] [Related]
9. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.
Larochelle S; Merrick KA; Terret ME; Wohlbold L; Barboza NM; Zhang C; Shokat KM; Jallepalli PV; Fisher RP
Mol Cell; 2007 Mar; 25(6):839-50. PubMed ID: 17386261
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity.
Nagahara H; Ezhevsky SA; Vocero-Akbani AM; Kaldis P; Solomon MJ; Dowdy SF
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14961-6. PubMed ID: 10611320
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
12. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
Paternot S; Colleoni B; Bisteau X; Roger PP
Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
14. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.
Coulonval K; Vercruysse V; Paternot S; Pita JM; Corman R; Raspé E; Roger PP
Cell Cycle; 2022 Jan; 21(1):12-32. PubMed ID: 34913830
[TBL] [Abstract][Full Text] [Related]
16. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ
Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
Wang W; Smith R; Safe S
Arch Biochem Biophys; 1998 Aug; 356(2):239-48. PubMed ID: 9705214
[TBL] [Abstract][Full Text] [Related]
18. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
[TBL] [Abstract][Full Text] [Related]
19. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
Henri P; Prevel C; Pellerano M; Lacotte J; Stoebner PE; Morris MC; Meunier L
Br J Dermatol; 2020 Mar; 182(3):678-689. PubMed ID: 31145809
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis.
Coulonval K; Bockstaele L; Paternot S; Roger PP
J Biol Chem; 2003 Dec; 278(52):52052-60. PubMed ID: 14551212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
